García-Velasco JA - Search Results

1

GnRH-agonist triggering to avoid ovarian hyperstimulation syndrome: a review of the evidence.

Martinez MC, Ruiz FJ, García-Velasco JA. Martinez MC, et al. Curr Drug Targets. 2013 Jul;14(8):843-9. doi: 10.2174/13894501113149990163. Curr Drug Targets. 2013. PMID: 23614678 Review.

2

Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).

Garcia-Velasco JA, Isaza V, Vidal C, Landazábal A, Remohí J, Simón C, Pellicer A. Garcia-Velasco JA, et al. Hum Reprod. 2001 Dec;16(12):2533-9. doi: 10.1093/humrep/16.12.2533. Hum Reprod. 2001. PMID: 11726570

3

New concepts in the understanding of the ovarian hyperstimulation syndrome.

Garcia-Velasco JA, Pellicer A. Garcia-Velasco JA, et al. Curr Opin Obstet Gynecol. 2003 Jun;15(3):251-6. doi: 10.1097/00001703-200306000-00007. Curr Opin Obstet Gynecol. 2003. PMID: 12858114 Review.

4

Coasting acts through downregulation of VEGF gene expression and protein secretion.

García-Velasco JA, Zúñiga A, Pacheco A, Gómez R, Simón C, Remohí J, Pellicer A. García-Velasco JA, et al. Hum Reprod. 2004 Jul;19(7):1530-8. doi: 10.1093/humrep/deh298. Epub 2004 May 20. Hum Reprod. 2004. PMID: 15155606

5

Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?

García-Velasco JA, Isaza V, Quea G, Pellicer A. García-Velasco JA, et al. Fertil Steril. 2006 Mar;85(3):547-54. doi: 10.1016/j.fertnstert.2005.07.1335. Fertil Steril. 2006. PMID: 16500317 Free article. Review.

6

Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome.

Villasante A, Pacheco A, Ruiz A, Pellicer A, Garcia-Velasco JA. Villasante A, et al. J Clin Endocrinol Metab. 2007 Jan;92(1):314-21. doi: 10.1210/jc.2006-1231. Epub 2006 Oct 10. J Clin Endocrinol Metab. 2007. PMID: 17032719

7

High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist.

Garcia-Velasco JA, Coelingh Bennink HJ, Epifanio R, Escudero E, Pellicer A, Simón C. Garcia-Velasco JA, et al. Reprod Biomed Online. 2007 Sep;15(3):280-7. doi: 10.1016/s1472-6483(10)60340-9. Reprod Biomed Online. 2007. PMID: 17854525 Clinical Trial.

8

Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.

Villasante A, Pacheco A, Pau E, Ruiz A, Pellicer A, Garcia-Velasco JA. Villasante A, et al. Hum Reprod. 2008 Mar;23(3):662-7. doi: 10.1093/humrep/dem429. Epub 2008 Jan 23. Hum Reprod. 2008. PMID: 18216038

9

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.

Soares SR, Gómez R, Simón C, García-Velasco JA, Pellicer A. Soares SR, et al. Hum Reprod Update. 2008 Jul-Aug;14(4):321-33. doi: 10.1093/humupd/dmn008. Epub 2008 Apr 2. Hum Reprod Update. 2008. PMID: 18385260 Review.

10

GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.

Giles J, Requena A, García-Velasco JA, Pacheco A, Pellicer J, Pellicer A. Giles J, et al. Fertil Steril. 2009 Apr;91(4 Suppl):1366-9. doi: 10.1016/j.fertnstert.2008.04.017. Epub 2008 Aug 9. Fertil Steril. 2009. PMID: 18692821 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters